FDA Approves A New, Monoclonal Antibody For Lymphoma
Better Health,
Recently, the FDA announced its approval, upon accelerated review, of a new drug, Adcetris (brentuximab) for patients with…
CD30: an important new target in hematologic malignancies
Overview of attention for article published in Leukemia & Lymphoma, May 2011
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Readers on
- mendeley
- 37 Mendeley
- citeulike
- 1 CiteULike